Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
No Data
Vor Biopharma Shareholders Back Directors and Governance Measures
Vor Bio Partner Drug Earns Regulatory Approval In China For Sjogren's Disease
Express News | Telitacicept Receives Nmpa Conditional Approval for the Treatment of Iga Nephropathy in China
Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China
Vor Biopharma's Phase 3 Sjögren's Trial Puts Telitacicept on Investors' Radar
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)